Production (Stage)
Nuo Therapeutics, Inc.
AURX
$1.58
-$0.12-7.06%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -746.10K | -496.70K | -578.20K | -540.10K | -708.80K |
| Total Depreciation and Amortization | 32.60K | 28.40K | 20.50K | 19.90K | 27.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.00K | -42.10K | 50.90K | 3.10K | 20.60K |
| Change in Net Operating Assets | 674.40K | 19.90K | 19.30K | -174.10K | 98.20K |
| Cash from Operations | 1.80K | -490.50K | -487.50K | -691.20K | -562.40K |
| Capital Expenditure | -229.90K | 0.00 | -150.90K | -4.10K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -229.90K | 0.00 | -150.90K | -4.10K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 90.40K | 849.10K | 802.10K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 90.40K | 849.10K | 802.10K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.10K | -400.10K | 210.80K | 106.80K | -562.40K |